Toxoplasmosis vaccines: what we have and where to go?
Top Cited Papers
Open Access
- 31 October 2022
- journal article
- review article
- Published by Springer Nature in npj Vaccines
- Vol. 7 (1) , 1-8
Abstract
Despite recent major advances in developing effective vaccines against toxoplasmosis, finding new protective vaccination strategies remains a challenging and elusive goal as it is critical to prevent the disease. Over the past few years, various experimental approaches have shown that developing an effective vaccine against T. gondii is achievable. However, more remains unknown due to its complicated life cycle, difficulties in clinical translation, and lack of a standardized platform. This minireview summarizes the recent advances in the development of T. gondii vaccines and the main obstacles to developing a safe, effective and durable T. gondii vaccine. The successes and failures in developing and testing vaccine candidates for the T. gondii vaccine are also discussed, which may facilitate the future development of T. gondii vaccines.Keywords
This publication has 89 references indexed in Scilit:
- Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineagesProceedings of the National Academy of Sciences, 2012
- The IRG protein-based resistance mechanism in mice and its relation to virulence in Toxoplasma gondiiCurrent Opinion in Microbiology, 2011
- Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North AmericaInternational Journal for Parasitology, 2011
- Protective Immunity Induced by Toxoplasma gondii Rhoptry Protein 16 against Toxoplasmosis in MiceClinical and Vaccine Immunology, 2011
- Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondiiImmunome Research, 2010
- Toxoplasmosis in sheep—The last 20 yearsVeterinary Parasitology, 2009
- DNA vaccines: ready for prime time?Nature Reviews Genetics, 2008
- Cost-Effectiveness Analyses of Vaccination ProgrammesPharmacoEconomics, 2008
- Toxoplasma gondii Comprises Three Clonal Lineages: Correlation of Parasite Genotype with Human DiseaseThe Journal of Infectious Diseases, 1995
- Toxoplasmosis: the first commercial vaccineParasitology Today, 1993